Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 18.6B | 20.2B | 23.6B | 21.4B |
Cost of revenue | 12.5B | 13.4B | 15.7B | 14.3B |
Gross profit | 6.1B | 6.8B | 7.9B | 7.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.8B | 3.8B | 4.0B | 4.0B |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 2.5B | 3.4B | 2.7B |
Non operating interest income | ||||
Income | 35M | 50M | 52M | 21M |
Expense | 363M | 367M | 369M | 373M |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 2.2B | 3.1B | 2.3B |
Tax provision | 378M | 524M | 747M | 546M |
Net income | 1.1B | 1.7B | 2.4B | 1.8B |
Basic EPS | — | 3.0 | 4.2 | 3.1 |
Diluted EPS | — | 3.0 | 4.2 | 3.1 |
Basic average shares | — | 630.6M | 634.0M | 637.3M |
Diluted average shares | — | 631.7M | 636.2M | 638.4M |
EBITDA | 2.4B | 3.1B | 4.0B | 3.2B |
Net income from continuing op. | 1.1B | 1.7B | 2.4B | 1.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | 2M | 4M | 6M | 5M |